Researchers have developed a working prototype of a PCR test for monkeypox that provides accurate, easy-to-read results The test works with a compact, portable system developed for COVID-19 ...
The Michigan startup uses a proprietary approach called processor-mediated PCR to enable high-plex, low-cost testing in a ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...
SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
Modern diagnostic methods allow growers to detect pathogens earlier and identify disease pressure with far greater precision ...
Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results